(SRTY) ProShares UltraPro Short - Overview
Etf: Inverse, Leveraged, ETF, Russell, Exposure
Dividends
| Dividend Yield | 5.10% |
| Yield on Cost 5y | 0.70% |
| Yield CAGR 5y | 142.49% |
| Payout Consistency | 55.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 66.6% |
| Relative Tail Risk | 0.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.64 |
| Alpha | -15.31 |
| Character TTM | |
|---|---|
| Beta | -3.102 |
| Beta Downside | -2.996 |
| Drawdowns 3y | |
|---|---|
| Max DD | 84.75% |
| CAGR/Max DD | -0.45 |
Description: SRTY ProShares UltraPro Short December 22, 2025
The ProShares UltraPro Short Russell 2000 (NYSE ARCA: SRTY) seeks to deliver **-3× the daily performance** of the Russell 2000 Index, a benchmark of U.S. small-cap equities. It does so by holding a mix of futures, swaps, and other derivatives that together should generate inverse leveraged exposure equal to at least 80 % of the fund’s assets.
Key quantitative traits (as of the latest filing) include an **expense ratio of 0.95 %**, a **daily reset mechanism** that can cause return drift over longer horizons, and a **non-diversified** structure that concentrates risk in a limited set of derivative contracts. The fund’s **beta to the Russell 2000** is approximately **-3.0 on a one-day basis**, but the effective beta can deviate significantly over multi-day periods due to compounding.
Macro-level drivers that most directly impact SRTY’s performance are **U.S. small-cap earnings trends**, **interest-rate expectations**, and **overall market risk appetite**. In a rising-rate environment, small-cap stocks often underperform larger, more cash-rich firms, which can amplify the inverse return for SRTY. Conversely, a broad risk-on rally can quickly erode its value.
Because the fund resets its leverage daily, **holding periods longer than one day introduce path-dependency risk**; investors should treat SRTY as a short-term tactical tool rather than a buy-and-hold position.
For a deeper quantitative breakdown, the ValueRay platform offers granular performance analytics you may find useful.
What is the price of SRTY shares?
Over the past week, the price has changed by -6.72%, over one month by -10.46%, over three months by -27.46% and over the past year by -47.58%.
Is SRTY a buy, sell or hold?
What are the forecasts/targets for the SRTY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 25.3 | -25% |
SRTY Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 86.4m USD (86.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 86.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 86.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = -5.52% (negative - check inputs) (E(86.4m)/V(86.4m) * Re(-5.52%) + (debt-free company))
Discount Rate = 9.60% (= Risk Free + ERP)
Fair Price DCF = unknown (Cash Flow 0.0)